Evidence map›Paper›PMID 41246000›Full record

ArticleInfection and drug resistance2025

Epidemiology and Antifungal Susceptibility Trends of Candidemia: A 5-Year Retrospective Study at King Abdulaziz University Hospital.

Shaymaa A Abdalal, Dalya M Attallah, Jawahir A Mokhtar, Reham Mohammedsaeed Kaki, Hatoon A Niyazi, Hanouf A Niyazi, Moroj A Aldarmasi

Abstract read
In one paragraph

Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Non-Life (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shaymaa A AbdalalCommunity Medicine Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0003-4354-8976
Dalya M AttallahClinical and Molecular Microbiology Laboratories, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.ORCID 0009-0006-0082-1177
Jawahir A MokhtarClinical Microbiology and Immunology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0001-7563-6941
Reham Mohammedsaeed KakiDepartment of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Hatoon A NiyaziClinical and Molecular Microbiology Laboratories, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Hanouf A NiyaziClinical Microbiology and Immunology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Moroj A AldarmasiCommunity Medicine Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Candidemia, a bloodstream infection caused by Candida species, poses a significant clinical challenge, especially in immunocompromised individuals and intensive care unit (ICU) patients. Prompt diagnosis and treatment are crucial, as delayed antifungal therapy is associated with higher mortality rates. This study, conducted at King Abdulaziz University Hospital (KAUH) in Saudi Arabia, aimed to investigate the clinical and microbiological aspects of candidemia. Methods: This study is a retrospective analysis, KAUH in Saudi Arabia, using data from January 2017 to March 2021. Advanced fungal diagnostic technologies, including MALDI-TOF MS, BioFire, and Vitek 2 systems, were utilized. Patient demographics, clinical characteristics, Candida species distribution, and antifungal susceptibility were assessed. Univariate, bivariate, and multivariate statistical analyses were conducted. Results: Among 418 patients, Conclusion: This study provides valuable insights into the epidemiology and clinical characteristics of candidemia at KAUH, highlighting the importance of species identification and tailored antifungal therapy. These findings can inform strategies to improve patient care and infection control in Saudi Arabian healthcare settings, contributing to global efforts to mitigate the impact of invasive fungal infections.

Indexed as

antifungal susceptibilityCandida speciescandidemiaepidemiologySaudi Arabia

Identifiers

PMID41246000
PMCPMC12619646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.